T-CELL LYMPHOMA
Clinical trials for T-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new T-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for T-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Cancer drug tested for new use in rare lymphoma, but study stopped early
Disease control TerminatedThis early-stage study tested the safety of the drug tazemetostat in people with a rare type of blood cancer called peripheral T-cell lymphoma that had come back or not responded to treatment. Only 6 people took part before the study was stopped. The goal was to find a safe dose …
Matched conditions: T-CELL LYMPHOMA
Phase: PHASE1 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
Lymphoma study halted early: drug after transplant shows limited promise
Disease control TerminatedThis study looked at whether a drug called duvelisib could help keep T-cell lymphoma from returning after a stem cell transplant. The trial was stopped early and included 17 adults with certain types of T-cell lymphoma. The goal was to see if the drug was safe and could improve h…
Matched conditions: T-CELL LYMPHOMA
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 11, 2026 20:46 UTC